These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 2576023
1. Effects of some antipsychotic drugs on cardiovascular catecholamine receptors in the rat. Cuffí ML, Vila E, Badia A. J Auton Pharmacol; 1989 Dec; 9(6):397-409. PubMed ID: 2576023 [Abstract] [Full Text] [Related]
2. Effects of bromocriptine on catecholamine receptors mediating cardiovascular responses in the pithed rat. Vila E, Badia A, Jane F. J Auton Pharmacol; 1985 Jun; 5(2):125-30. PubMed ID: 2991290 [Abstract] [Full Text] [Related]
3. Inhibitory dopamine receptors on sympathetic neurons innervating the cardiovascular system of the pithed rat. Characterization and role in relation to presynaptic alpha 2-adrenoceptors. Wilffert B, Smit G, de Jonge A, Thoolen MJ, Timmermans PB, van Zwieten PA. Naunyn Schmiedebergs Arch Pharmacol; 1984 Jun; 326(2):91-8. PubMed ID: 6089003 [Abstract] [Full Text] [Related]
8. Effects of DA-1- and DA-2-dopamine antagonists on apomorphine-induced inhibition of peripheral sympathetic neurotransmission. Hietala J. J Auton Pharmacol; 1988 Dec; 8(4):297-302. PubMed ID: 2855331 [Abstract] [Full Text] [Related]
9. Effects of acute or long-term treatment with chlorpromazine, haloperidol or sulpiride on neuropeptide Y-like immunoreactivity concentrations in the nucleus accumbens of rat. Obuchowicz E, Turchan J. Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):51-9. PubMed ID: 10082228 [Abstract] [Full Text] [Related]
11. In vivo potencies of antipsychotic drugs in blocking alpha 1 noradrenergic and dopamine D2 receptors: implications for drug mechanisms of action. Cohen BM, Lipinski JF. Life Sci; 1986 Dec 29; 39(26):2571-80. PubMed ID: 2879204 [Abstract] [Full Text] [Related]
13. Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain. Ogren SO, Hall H, Köhler C, Magnusson O, Lindbom LO, Angeby K, Florvall L. Eur J Pharmacol; 1984 Jul 20; 102(3-4):459-74. PubMed ID: 6149133 [Abstract] [Full Text] [Related]
14. A comparison of the cardiovascular effects of haloperidol, thioridazine and chlorpromazine HCl. Brannan MD, Riggs JJ, Hageman WE, Pruss TP. Arch Int Pharmacodyn Ther; 1980 Mar 20; 244(1):48-57. PubMed ID: 6251766 [Abstract] [Full Text] [Related]
15. Cardiovascular effects of bromocriptine in rats: role of peripheral adrenergic and dopaminergic receptors. Roquebert J, Alaoui K, Morán Benito A. J Auton Pharmacol; 1990 Apr 20; 10(2):85-96. PubMed ID: 2161850 [Abstract] [Full Text] [Related]
16. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat. Alkadhi KA, Sabouni MH, Ansari AF, Lokhandwala MF. J Pharmacol Exp Ther; 1986 Aug 20; 238(2):547-53. PubMed ID: 2874213 [Abstract] [Full Text] [Related]
17. Behavioural interactions between 5-hydroxytryptophan, neuroleptic agents and 5-HT receptor antagonists in modifying rodent responding to aversive situations. Costall B, Naylor RJ. Br J Pharmacol; 1995 Dec 20; 116(7):2989-99. PubMed ID: 8680734 [Abstract] [Full Text] [Related]
18. Atypical neuroleptics suppress dopaminergic behavioral supersensitivity. Schremmer C, Morgenstern R, Fink H, Ott T. Psychopharmacology (Berl); 1990 Dec 20; 100(3):399-403. PubMed ID: 1969173 [Abstract] [Full Text] [Related]
19. Involvement of different dopamine receptors in rat diphasic motility response to apomorphine. Vaccheri A, Dall'Olio R, Gandolfi O, Montanaro N. Psychopharmacology (Berl); 1986 Dec 20; 89(3):265-8. PubMed ID: 2873607 [Abstract] [Full Text] [Related]